Literature DB >> 20516647

Uric acid transport and disease.

Alexander So1, Bernard Thorens.   

Abstract

Uric acid is the metabolic end product of purine metabolism in humans. It has antioxidant properties that may be protective but can also be pro-oxidant, depending on its chemical microenvironment. Hyperuricemia predisposes to disease through the formation of urate crystals that cause gout, but hyperuricemia, independent of crystal formation, has also been linked with hypertension, atherosclerosis, insulin resistance, and diabetes. We discuss here the biology of urate metabolism and its role in disease. We also cover the genetics of urate transport, including URAT1, and recent studies identifying SLC2A9, which encodes the glucose transporter family isoform Glut9, as a major determinant of plasma uric acid levels and of gout development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20516647      PMCID: PMC2877959          DOI: 10.1172/JCI42344

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  104 in total

Review 1.  Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?

Authors:  Richard J Johnson; Mark S Segal; Titte Srinivas; Ahsan Ejaz; Wei Mu; Carlos Roncal; Laura G Sánchez-Lozada; Michael Gersch; Bernardo Rodriguez-Iturbe; Duk-Hee Kang; Jaime Herrera Acosta
Journal:  J Am Soc Nephrol       Date:  2005-04-20       Impact factor: 10.121

2.  Expression of the GLUT1 and GLUT9 facilitative glucose transporters in embryonic chondroblasts and mature chondrocytes in ovine articular cartilage.

Authors:  A Mobasheri; H Dobson; S L Mason; F Cullingham; M Shakibaei; J F Moley; K H Moley
Journal:  Cell Biol Int       Date:  2005-03-17       Impact factor: 3.612

3.  Uric acid oxidation by peroxynitrite: multiple reactions, free radical formation, and amplification of lipid oxidation.

Authors:  C X Santos; E I Anjos; O Augusto
Journal:  Arch Biochem Biophys       Date:  1999-12-15       Impact factor: 4.013

4.  Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells.

Authors:  Sergey Zharikov; Karina Krotova; Hanbo Hu; Chris Baylis; Richard J Johnson; Edward R Block; Jawaharlal Patel
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-10       Impact factor: 4.249

5.  Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice.

Authors:  Stéphane Cook; Olivier Hugli; Marc Egli; Peter Vollenweider; Rémy Burcelin; Pascal Nicod; Bernard Thorens; Urs Scherrer
Journal:  Swiss Med Wkly       Date:  2003-06-28       Impact factor: 2.193

Review 6.  Role of insulin resistance in human disease (syndrome X): an expanded definition.

Authors:  G M Reaven
Journal:  Annu Rev Med       Date:  1993       Impact factor: 13.739

7.  Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study.

Authors:  E W Campion; R J Glynn; L O DeLabry
Journal:  Am J Med       Date:  1987-03       Impact factor: 4.965

8.  Mouse GLUT9: evidences for a urate uniporter.

Authors:  Stéphanie Bibert; Solange Kharoubi Hess; Dmitri Firsov; Bernard Thorens; Käthi Geering; Jean-Daniel Horisberger; Olivier Bonny
Journal:  Am J Physiol Renal Physiol       Date:  2009-07-08

9.  Uric acid level and its association with carotid intima-media thickness in patients with hypertension.

Authors:  Yusuf Tavil; Mehmet Güngör Kaya; Suna Ozhan Oktar; Nihat Sen; Kaan Okyay; Hüseyin Uğur Yazici; Atiye Cengel
Journal:  Atherosclerosis       Date:  2007-04-09       Impact factor: 5.162

10.  Sex-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI.

Authors:  Anita Brandstätter; Stefan Kiechl; Barbara Kollerits; Steven C Hunt; Iris M Heid; Stefan Coassin; Johann Willeit; Ted D Adams; Thomas Illig; Paul N Hopkins; Florian Kronenberg
Journal:  Diabetes Care       Date:  2008-05-16       Impact factor: 19.112

View more
  225 in total

1.  Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function.

Authors:  Justine Bacchetta; Pierre Cochat; Isidro B Salusky; Katherine Wesseling-Perry
Journal:  Pediatr Nephrol       Date:  2012-02-05       Impact factor: 3.714

2.  Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization.

Authors:  M J Gold; P R Hiebert; H Y Park; D Stefanowicz; A Le; M R Starkey; A Deane; A C Brown; G Liu; J C Horvat; Z A Ibrahim; M B Sukkar; P M Hansbro; C Carlsten; S VanEeden; D D Sin; K M McNagny; D A Knight; J A Hirota
Journal:  Mucosal Immunol       Date:  2015-10-28       Impact factor: 7.313

3.  Genetic polymorphisms in the PDZK1 gene and susceptibility to gout in male Han Chinese: a case-control study.

Authors:  Ming Li; Qiang Li; Chang-Gui Li; Min Guo; Jin-Mei Xu; Ying-Ying Tang; Qing-Song Zhao; Yu-Hua Hu; Zhi-Feng Cheng; Jin-Chao Zhang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Clinical, Genetic, and Urinary Factors Associated with Uromodulin Excretion.

Authors:  Stéphan Troyanov; Catherine Delmas-Frenette; Guillaume Bollée; Sonia Youhanna; Vanessa Bruat; Philip Awadalla; Olivier Devuyst; François Madore
Journal:  Clin J Am Soc Nephrol       Date:  2015-12-18       Impact factor: 8.237

5.  Association between SLC2A9 transporter gene variants and uric acid phenotypes in African American and white families.

Authors:  Andrew D Rule; Mariza de Andrade; Martha Matsumoto; Tom H Mosley; Sharon Kardia; Stephen T Turner
Journal:  Rheumatology (Oxford)       Date:  2010-12-24       Impact factor: 7.580

Review 6.  Tubular transport: core curriculum 2010.

Authors:  Marta Christov; Seth L Alper
Journal:  Am J Kidney Dis       Date:  2010-10-30       Impact factor: 8.860

7.  Uric acid: a modulator of prostate cells and activin sensitivity.

Authors:  Febbie Sangkop; Geeta Singh; Ely Rodrigues; Elspeth Gold; Andrew Bahn
Journal:  Mol Cell Biochem       Date:  2016-02-24       Impact factor: 3.396

Review 8.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

9.  Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug Toxicity.

Authors:  Ling Zou; Adrian Stecula; Anshul Gupta; Bhagwat Prasad; Huan-Chieh Chien; Sook Wah Yee; Li Wang; Jashvant D Unadkat; Simone H Stahl; Katherine S Fenner; Kathleen M Giacomini
Journal:  Mol Pharmacol       Date:  2018-05-02       Impact factor: 4.436

10.  ABCG2 requires a single aromatic amino acid to "clamp" substrates and inhibitors into the binding pocket.

Authors:  Tomoka Gose; Talha Shafi; Yu Fukuda; Sourav Das; Yao Wang; Alice Allcock; Ailsa Gavan McHarg; John Lynch; Taosheng Chen; Ikumi Tamai; Anang Shelat; Robert C Ford; John D Schuetz
Journal:  FASEB J       Date:  2020-02-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.